2023
DOI: 10.1002/mc.23501
|View full text |Cite
|
Sign up to set email alerts
|

Plasma cell‐free DNA methylome profiling in pre‐ and post‐surgery oral cavity squamous cell carcinoma

Abstract: Head and neck squamous cell carcinoma (HNSCC), a highly heterogeneous disease that involves multiple anatomic sites, is a leading cause of cancer-related mortality worldwide. Although the utility of noninvasive biomarkers based on circulating cellfree DNA (cfDNA) methylation profiling has been widely recognized, limited studies have been reported so far regarding the dynamics of cfDNA methylome in oral cavity squamous cell carcinoma (OCSCC). It is hypothesized in this study that comparison of methylation profi… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 66 publications
0
7
0
Order By: Relevance
“…Interestingly, the top five validated differentially methylated were located in the promoter region of the genes PENK, NXPH1, ZIK1, TBXT , and CDO1 . In addition, they found that the methylation of SFRP4, SOX1, IRF4 , and PCDH17 was associated with the overall survival of HNC patients, supporting its utility as prognostic biomarkers [86] .…”
Section: Applications Of Cell-free Dna In Head and Neck Cancermentioning
confidence: 90%
See 1 more Smart Citation
“…Interestingly, the top five validated differentially methylated were located in the promoter region of the genes PENK, NXPH1, ZIK1, TBXT , and CDO1 . In addition, they found that the methylation of SFRP4, SOX1, IRF4 , and PCDH17 was associated with the overall survival of HNC patients, supporting its utility as prognostic biomarkers [86] .…”
Section: Applications Of Cell-free Dna In Head and Neck Cancermentioning
confidence: 90%
“…However, the performance of these biomarkers could be affected by the different methodological design of each study as well as the different preanalytical and postanalytical factors. Thus, the size of study cohort represents one of the most frequent limitations in the investigations [80] , [84] , [86] , [87] , so a further validation in an independent cohort is required to validate the performance of methylation biomarkers. Regarding the patient clinicopathological characteristics, the TNM stage was specified in only three studies [80] , [82] , [84] whereas the HPV status was described in one research [84] .…”
Section: Applications Of Cell-free Dna In Head and Neck Cancermentioning
confidence: 99%
“…Wang et al emphasized the value of saliva by measuring cfDNA in saliva in 100% and in serum in 80% of oral cavity squamous cell carcinoma (OCSCC) (33). In a small study, plasma cell free DNA methylome analysis was feasible in OCSCC and with prognostic relevance (34). Zhou et al proposed a method for early cancer detection using tumor fractions deciphered from circulation cfDNA methylation signatures achieving 86.1% sensitivity for cancer detection at a speci city of 94.7% and an average localization accuracy of 76.9% (35).…”
Section: Discussionmentioning
confidence: 99%
“…OSF has a very high malignant potential rate into OSCC (33). The survival rate of OSCC ve-years has not been improved since many decades (34). Therefore, there is a serious, urgent and ongoing need to identify and discover noninvasive technique such as salivary biomarkers in OSF which will help us in early identi cation of its malignant potential (35,36).…”
Section: Discussionmentioning
confidence: 99%